Literature DB >> 197128

Human lung tissue and anaphylaxis. Evidence that cyclic nucleotides modulate the immunologic release of mediators through effects on microtubular assembly.

M Kaliner.   

Abstract

The addition of specific antigen to IgE-sensitized human lung tissue causes the secretion of the mediators histamine and slow-reacting substance of anaphylaxis. The mechanisms by which increased levels of cyclic AMP suppress and increased levels of cyclic GMP enhance this secretory process were studied. Colchicine, an agent which disrupts many secretory reactions by binding to microtubules in their disassembled 6S form, was a relatively ineffective inhibitor of the antigen-induced release of mediators unless lung fragments were incubated at 4 degrees C for 60 min to induce microtubular disassembly. As colchicine appeared to inhibit the immunologic secretion of mediators from human lung tissue most effectively after microtubular disassembly, the capacity of colchicine to modulate the release reaction indicated the state of microtubular assembly; inhibition by colchicine signaled a shift to the colchicine-sensitive 6S subunits whereas failure to inhibit suggested maintenance in the colchicine-resistant polymerized state.Exogenously added 8-Bromo-cyclic GMP prevented low temperature-facilitated colchicine suppression of mediator release suggesting that increased levels of cyclic GMP stabilize polymerized microtubules. Transiently increased cyclic AMP concentrations, either exogenously added as 8-Bromo-cyclic AMP or endogenously produced by isoproterenol, promoted colchicine suppression of mediator release suggesting that microtubular disassembly was produced. Direct measurement of cyclic AMP levels revealed parallel kinetics after isoproterenol stimulation between control and colchicine-treated lung fragments. The requirement for functional microtubules in the release reaction may occur after the antigen IgE-stimulated activation of a serine esterase, energy utilization, and an intracellular calcium requirement. The mechanism by which cyclic nucleotides influence microtubular assembly is postulated to involve the degree of phosphorylation-dephosphorylation of microtubules.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197128      PMCID: PMC372444          DOI: 10.1172/JCI108850

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Action of drugs on microtubules.

Authors:  L Wilson
Journal:  Life Sci       Date:  1975-08-01       Impact factor: 5.037

2.  Enzymatic acitivity in tubulin preparations: cyclic-AMP dependent protein kinase activity of brain microtubule protein.

Authors:  D Soifer
Journal:  J Neurochem       Date:  1975-01       Impact factor: 5.372

Review 3.  Reciprocal effects of cAMP and cGMP on microtubule-dependent release of lysosomal enzymes.

Authors:  G Weissmann; I Goldstein; S Hoffstein; P K Tsung
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

4.  Reversible inhibition of cAMP-induced axon formation in neuroblastoma cells by concanavalin A and vinblastine. Relationship to microtubules and cytotoxicity.

Authors:  R Simantov; U Rutishauser; L Sachs
Journal:  Exp Cell Res       Date:  1975-10-15       Impact factor: 3.905

5.  Phosphorylation of microtubule-associated proteins.

Authors:  L Rappaport; J F Leterrier; A Virion; J Nunez; J Osty
Journal:  Eur J Biochem       Date:  1976-03-01

6.  Cyclic AMP-dependent endogenous phosphorylation of a microtubule-associated protein.

Authors:  R D Sloboda; S A Rudolph; J L Rosenbaum; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Opposing effects of cyclic AMP and cyclic GMP on protein phosphorylation in tubulin preparations.

Authors:  I V Sandoval; P Cuatrecasas
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

9.  Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists.

Authors:  J M Oliver; R B Zurier
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

10.  Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate.

Authors:  L A Boxer; A M Watanabe; M Rister; H R Besch; J Allen; R L Baehner
Journal:  N Engl J Med       Date:  1976-11-04       Impact factor: 91.245

View more
  4 in total

Review 1.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09

2.  The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.

Authors:  L F Platshon; M Kaliner
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

3.  Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (--)[3H]-dihydroalprenolol binding and inhibition of histamine release.

Authors:  E Masini; R Fantozzi; P Blandina; A Galli; T Bani-Sacchi; A Giotti; L Zilletti; P F Mannaioni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

4.  Preparation of a human lung purified plasma membrane fraction: confirmation by enzyme markers, electron microscopy, and histamine H1 receptor binding.

Authors:  T B Casale; M Friedman; N Parada; J Plekes; M Kaliner
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.